Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206119
Company: PAR PHARM INC

Products on ANDA 206119

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TOLVAPTAN	TOLVAPTAN	15MG	TABLET;ORAL	Prescription	AB	No	No
TOLVAPTAN	TOLVAPTAN	30MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 206119

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/15/2022	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/206119Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 206119

TOLVAPTAN

TABLET;ORAL; 15MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
SAMSCA	TOLVAPTAN	15MG	TABLET;ORAL	Prescription	Yes	AB	022275	OTSUKA
TOLVAPTAN	TOLVAPTAN	15MG	TABLET;ORAL	Prescription	No	AB	211891	ALKEM LABS LTD
TOLVAPTAN	TOLVAPTAN	15MG	TABLET;ORAL	Prescription	No	AB	207605	APOTEX
TOLVAPTAN	TOLVAPTAN	15MG	TABLET;ORAL	Prescription	No	AB	205646	HETERO LABS LTD V
TOLVAPTAN	TOLVAPTAN	15MG	TABLET;ORAL	Prescription	No	AB	216949	MSN
TOLVAPTAN	TOLVAPTAN	15MG	TABLET;ORAL	Prescription	No	AB	206119	PAR PHARM INC

TABLET;ORAL; 30MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
SAMSCA	TOLVAPTAN	30MG	TABLET;ORAL	Prescription	Yes	AB	022275	OTSUKA
TOLVAPTAN	TOLVAPTAN	30MG	TABLET;ORAL	Prescription	No	AB	211891	ALKEM LABS LTD
TOLVAPTAN	TOLVAPTAN	30MG	TABLET;ORAL	Prescription	No	AB	207605	APOTEX
TOLVAPTAN	TOLVAPTAN	30MG	TABLET;ORAL	Prescription	No	AB	205646	HETERO LABS LTD V
TOLVAPTAN	TOLVAPTAN	30MG	TABLET;ORAL	Prescription	No	AB	216949	MSN
TOLVAPTAN	TOLVAPTAN	30MG	TABLET;ORAL	Prescription	No	AB	206119	PAR PHARM INC